Clinical Trials

1,100 enrolled

Lung Neoplasms

NCT03774732 2026-02-25

NIRVANA-LUNG

327 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04339218 2026-01-30

CRYOMUNE

214 enrolled

Adenocarcinoma of Lung

NCT04334759 2026-01-22

DREAM3R

Other solid neoplasmThoracic

214 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT05624996 2026-01-14

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

474 enrolled

Lung Neoplasms

NCT06908993 2025-12-17

COMET

133 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04695925 2025-10-15

TOP

294 enrolled

Non-small Cell Carcinoma

NCT06505837 2025-08-28

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

395 enrolled

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer

NCT01951482 2025-08-17

Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer

160 enrolled

CNS

Brain Neoplasms

NCT00284778 2025-07-24

Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer

150 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05692999 2025-06-25

Pulse

1,166 enrolled

Metastatic Non-squamous Lung Cancer

NCT04585490 2025-05-06

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

48 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04158141 2025-02-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

16 enrolled 18 charts

Mesothelioma, Malignant, Mesothelioma

NCT06704620 2024-12-16

Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer

Phase 3 Not yet recruiting

430 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05055908 2024-08-02

BECOME

12,000 enrolled

Lung Neoplasms

NCT04158440 2024-07-09

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

501 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01656551 2023-03-24

MILES-4

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01850303 2023-03-14

MODEL

632 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05648071 2022-12-13

SPBPDC

60 enrolled

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT01951469 2022-03-08

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

160 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02607592 2022-02-25

NACA

293 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04768075 2021-02-24

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04500704 2020-08-05

ACROSS1

166 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04500717 2020-08-05

ACROSS2

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02004184 2020-06-23

IDA

230 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

70 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT02900742 2019-04-12

Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer

71 enrolled

Lung Neoplasms, Neoplasms

NCT02162537 2019-02-01

METAL2

95 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03061058 2017-09-15

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

240 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03269162 2017-09-14

Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection

144 enrolled

NSCLC

NCT03193788 2017-06-21

PREMIER

74 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00976456 2016-03-10

65plus

271 enrolled 8 charts

Lung Neoplasms

NCT01282151 2015-07-14

TRAIL

148 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

392 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00005636 2013-06-19

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00440414 2010-08-19

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

320 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01066195 2010-02-10

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

129 enrolled